146 related articles for article (PubMed ID: 2701877)
1. The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
Selby G
Clin Exp Neurol; 1989; 26():129-39. PubMed ID: 2701877
[TBL] [Abstract][Full Text] [Related]
2. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
5. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
6. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
7. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Im JH; Ha JH; Cho IS; Lee MC
J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
[TBL] [Abstract][Full Text] [Related]
8. A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
Nakanishi T; Mizuno Y; Goto I; Iwata M; Kanazawa I; Kowa H; Mannen T; Nishitani H; Ogawa N; Takahashi A
Eur Neurol; 1988; 28 Suppl 1():3-8. PubMed ID: 3378560
[TBL] [Abstract][Full Text] [Related]
9. A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa.
Wallis WE
Eur Neurol; 1988; 28 Suppl 1():9-10. PubMed ID: 3288479
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Montastruc JL; Rascol O; Rascol A
Rev Neurol (Paris); 1990; 146(2):144-7. PubMed ID: 2181588
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of bromocriptine in the treatment of Parkinson's disease.
Mackenzie RA; Lance JW
Clin Exp Neurol; 1978; 15():228-36. PubMed ID: 386307
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
Jansen EN; Meerwaldt JD
Adv Neurol; 1987; 45():539-42. PubMed ID: 3103396
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
[TBL] [Abstract][Full Text] [Related]
14. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
15. [Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months].
Quattrini A; Paggi A; Del Pesce M; Di Bella P
Riv Patol Nerv Ment; 1978; 99(3):150-63. PubMed ID: 752907
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of early dopa treatment in Parkinson's disease.
Markham CH; Diamond SG
Ann Neurol; 1986 Apr; 19(4):365-72. PubMed ID: 3707088
[TBL] [Abstract][Full Text] [Related]
17. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
Fischer PA; Przuntek H; Majer M; Welzel D
Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
[TBL] [Abstract][Full Text] [Related]
18. "Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
Caraceni T; Giovannini P; Girotti F; Parati E; Pederzoli M; Scigliano G
Ital J Neurol Sci; 1981 Dec; 2(4):337-42. PubMed ID: 7333824
[TBL] [Abstract][Full Text] [Related]
19. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
20. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Factor SA; Weiner WJ
Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
